FDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’s
The drug, Kisunla, made by Eli Lilly, is the latest [...]
Hace casi un año se aprobó un fármaco para frenar el alzhéimer. ¿Ha funcionado?
Mientras la FDA estudia otro nuevo medicamento contra el alzhéimer, [...]
FDA Advisory Panel Endorses Approval of Alzheimer’s Drug Made by Eli Lilly
The modest benefits of the treatment, donanemab, made by Eli [...]
Leqembi and Alzheimer’s: What to Know About the New Drug, Treatment and Benefits
As the F.D.A. considers a new Alzheimer’s medication, we asked [...]
Ozempic Is Repairing a Hole in Our Diets Created by Processed Foods
Now is our chance to rethink the centuries-old stories we’ve [...]
Study Suggests Genetics as a Cause, Not Just a Risk, for Some Alzheimer’s
People with two copies of the gene variant APOE4 are [...]
A.L.S. Drug Relyvrio Will Be Taken Off the Market, Its Maker Says
Results of a large clinical trial found the treatment did [...]
¿Se puede tener alzhéimer y no presentar síntomas?
Una propuesta para cambiar los lineamientos de detección de la [...]
Powerful Psychedelic Drug Gains New Notice as an Opioid Addiction Therapy
New research is stirring interest in ibogaine, which appears to [...]
Apparently Healthy, but Diagnosed With Alzheimer’s?
New criteria could lead to a dementia diagnosis on the [...]